MD HYDRATION, INC. – Trademark Portfolio
Entity Type: 03
MD HYDRATION, INC. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include HAPPY SHOT, HYDRATION ROOM, JET LAG REVIVAL, HYDRATION REFRESH, and LONGEVITY INJECTION. The owner is based in Corona del Mar, CA.
3800 East Coast Highway, Suite 2
Corona del Mar, CA 92625
Showing of trademarks Trademarks
Trademark Classifications
MD HYDRATION, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MD HYDRATION, INC. have?
MD HYDRATION, INC. has 15 U.S. trademarks filed with the USPTO. Of these, 9 registered, 5 abandoned, 1 cancelled.
What trademark classes does MD HYDRATION, INC. file in?
MD HYDRATION, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are MD HYDRATION, INC.'s most well-known trademarks?
MD HYDRATION, INC.'s registered trademark portfolio includes well-known marks such as HAPPY SHOT, HYDRATION ROOM, JET LAG REVIVAL, HYDRATION REFRESH, and LONGEVITY INJECTION. These are among 9 currently registered trademarks in the portfolio.
What is MD HYDRATION, INC.'s trademark registration success rate?
MD HYDRATION, INC. has a 60% trademark registration rate, with 9 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.